Evommune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evommune and other ETFs, options, and stocks.About EVMN
Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases.
CEOLuis C. Peña
CEOLuis C. Peña
Employees41
Employees41
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2020
Founded2020
Employees41
Employees41
EVMN Key Statistics
Market cap526.45M
Market cap526.45M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume380.16K
Average volume380.16K
High today$19.63
High today$19.63
Low today$16.36
Low today$16.36
Open price$19.63
Open price$19.63
Volume191.54K
Volume191.54K
52 Week high$24.03
52 Week high$24.03
52 Week low$13.89
52 Week low$13.89
Stock Snapshot
With a market cap of 526.45M, Evommune(EVMN) trades at $17.13.
As of 2026-01-19, Evommune(EVMN) stock has fluctuated between $16.36 and $19.63. The current price stands at $17.13, placing the stock +4.7% above today's low and -12.7% off the high.
The Evommune(EVMN)'s current trading volume is 191.54K, compared to an average daily volume of 380.16K.
During the past year, Evommune(EVMN) stock moved between $13.89 at its lowest and $24.03 at its peak.
During the past year, Evommune(EVMN) stock moved between $13.89 at its lowest and $24.03 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own EVMN. This list is generated using Robinhood data, and it’s not a recommendation.